Finance

Lists
Why is MTEX down 29.84%?
Dive Deeper
MTEX:NASDAQ
Mannatech Inc
$6.30
-29.84%
(-2.68) 1D
Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MTEX...
Open
$8.04
High
$8.04
Low
$6.30
Mkt. cap
12.16M
Avg. vol.
31.34K
Volume
0.00
52-wk high
$9.97
52-wk low
$3.80
EPS
-$3.91
Beta
0.69
Shares outstanding
1.93M
No. of employees
170
Open
$8.04
High
$8.04
Low
$6.30
Mkt. cap
12.16M
Avg. vol.
31.34K
Volume
0.00
52-wk high
$9.97
52-wk low
$3.80
EPS
-$3.91
Beta
0.69
Shares outstanding
1.93M
No. of employees
170
News stories
From web sources and news partners
Profile
Mannatech Inc. is a publicly traded, multinational multi-level marketing firm that sells dietary supplements and personal care products. It was founded in November 1993 by Samuel Caster, and is headquartered in Flower Mound, Texas. The company's stock is traded on the NASDAQ exchange under the symbol MTEX. As of 2017, Mannatech employed 252 people and sold its products through some 220,000 independent sales associates. In 2007, Mannatech and its salespeople made false claims of anti-disease benefits about its lead product called "Ambrotose" which contains sugars derived from plants. The company was profitable soon after its founding until about 2008, when it started losing money due to exposure of its business practices through a class action lawsuit based on the false health claims, a critical 20/20 news special, and a civil suit filed by the Attorney General of Texas. Wikipedia
About Mannatech Inc
CEOAlfredo Bala
Employees170
FoundedNov 1993
HeadquartersFlower Mound, Texas, United States
SectorConsumer Staples
IndustryPersonal care products
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
26.64M
24.92M
26.65M
24.87M
Cost of goods sold
6.58M
6.06M
6.16M
6.29M
Cost of revenue
6.58M
6.06M
6.16M
6.29M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.20M
19.04M
19.49M
18.31M
Operating expense
20.20M
19.04M
19.49M
18.31M
Total operating expenses
26.79M
25.10M
25.65M
24.60M
Operating income
-153.00K
-180.00K
998.00K
272.00K
Other non operating income
39.00K
-
-16.00K
-2.11M
EBT including unusual items
210.00K
1.11M
1.16M
-1.95M
EBT excluding unusual items
210.00K
1.11M
1.16M
-1.95M
Income tax expense
11.50M
161.00K
150.00K
-10.86M
Effective tax rate
5,478.57%
14.49%
12.88%
555.73%
Other operating expenses
-
-
-
-
Net income
-11.30M
950.00K
1.02M
8.90M
Net profit margin
-42.41%
3.81%
3.81%
35.80%
Earnings per share
-
-
-
-
Interest and investment income
135.00K
-
-
-
Interest expense
-262.00K
-104.00K
-117.00K
-119.00K
Net interest expenses
-127.00K
-104.00K
-117.00K
-119.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
107.00K
81.00K
1.26M
518.00K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps